In addition, cancer therapies and the associated chemotherapy drugs can secondarily deplete the amount of NAD by causing DNA strand breaks by PARP activation, which can in some cases even result in clinical pellagra-like symptoms [68,69]. The gene discussed is PARP1; the disease is cancer.